New drug ICT01 aims to rally Body's defenses against tough cancers
Disease control
Ongoing
This study tests a new drug called ICT01, given alone or with the immunotherapy Keytruda, in people with advanced solid tumors or blood cancers that have come back or not responded to treatment. The goal is to see if ICT01 is safe and can help control the cancer by activating a s…
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:16 UTC